These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 1675791)

  • 1. Cloning and expression of the human vasoactive intestinal peptide receptor.
    Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.
    Sreedharan SP; Patel DR; Huang JX; Goetzl EJ
    Biochem Biophys Res Commun; 1993 Jun; 193(2):546-53. PubMed ID: 8390245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
    Hosoya M; Onda H; Ogi K; Masuda Y; Miyamoto Y; Ohtaki T; Okazaki H; Arimura A; Fujino M
    Biochem Biophys Res Commun; 1993 Jul; 194(1):133-43. PubMed ID: 7687425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and functional characterization of a human liver vasoactive intestinal peptide receptor.
    Gagnon AW; Aiyar N; Elshourbagy NA
    Cell Signal; 1994 Mar; 6(3):321-33. PubMed ID: 7917790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and expression of a human secretin receptor.
    Patel DR; Kong Y; Sreedharan SP
    Mol Pharmacol; 1995 Mar; 47(3):467-73. PubMed ID: 7700244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
    Ogi K; Miyamoto Y; Masuda Y; Habata Y; Hosoya M; Ohtaki T; Masuo Y; Onda H; Fujino M
    Biochem Biophys Res Commun; 1993 Nov; 196(3):1511-21. PubMed ID: 7902709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
    Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
    FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.
    Ishihara T; Shigemoto R; Mori K; Takahashi K; Nagata S
    Neuron; 1992 Apr; 8(4):811-9. PubMed ID: 1314625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of a recombinant human secretin receptor: a comparison with the rat and rabbit receptors.
    Di Paolo E; De Neef P; Moguilevsky N; Petry H; Cnudde J; Bollen A; Waelbroeck M; Robberecht P
    Pancreas; 1999 Jul; 19(1):51-5. PubMed ID: 10416692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
    Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
    Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and functional characterization of a human secretin receptor.
    Chow BK
    Biochem Biophys Res Commun; 1995 Jul; 212(1):204-11. PubMed ID: 7612008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
    O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
    J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.